AUD 1.3
(-4.07%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 9.89 Million AUD | 16.99% |
2023 | 8.45 Million USD | -60.28% |
2022 | 18.07 Million USD | 122.63% |
2021 | 8.2 Million AUD | 771.93% |
2020 | -1.22 Million AUD | 74.5% |
2019 | -4.79 Million AUD | -542.88% |
2018 | 1.07 Million AUD | 99.83% |
2017 | 542.07 Thousand AUD | -67.94% |
2016 | 1.56 Million AUD | 200.15% |
2015 | -3.34 Million AUD | 52.63% |
2014 | -3.86 Million AUD | -338.17% |
2013 | -948.32 Thousand AUD | -123.17% |
2012 | 3.63 Million AUD | 811.84% |
2011 | 164.2 Thousand AUD | -166.66% |
2010 | 739.83 Thousand AUD | -41.65% |
2009 | 1.26 Million AUD | 253.21% |
2008 | -800.07 Thousand AUD | 42.96% |
2007 | -1.45 Million AUD | -8.5% |
2006 | -1.8 Million AUD | 41.69% |
2005 | -2.29 Million AUD | -67.74% |
2004 | -1.36 Million AUD | -67.54% |
2003 | -816.03 Thousand AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q4 | 7.12 Million AUD | 0.0% |
2024 FY | - AUD | 87.1% |
2024 Q2 | 1.38 Million AUD | 0.0% |
2023 Q2 | -1.56 Million AUD | 0.0% |
2023 FY | - USD | -60.28% |
2023 Q4 | 8.78 Million AUD | 0.0% |
2022 Q4 | 11.41 Million AUD | 0.0% |
2022 Q2 | 6.92 Million AUD | 0.0% |
2022 FY | - USD | 122.63% |
2021 Q4 | 7.95 Million AUD | 0.0% |
2021 Q2 | -10.01 Thousand AUD | 0.0% |
2021 FY | - AUD | 771.93% |
2020 Q2 | -4.53 Million AUD | 0.0% |
2020 Q4 | 5.33 Million AUD | 0.0% |
2020 FY | - AUD | 74.5% |
2019 FY | - AUD | -542.88% |
2019 Q4 | -996.91 Thousand AUD | 0.0% |
2018 FY | - AUD | 99.83% |
2017 FY | - AUD | -67.94% |
2016 FY | - AUD | 200.15% |
2015 FY | - AUD | 52.63% |
2014 FY | - AUD | -338.17% |
2013 Q3 | -301.54 Thousand AUD | 0.0% |
2013 FY | - AUD | -123.17% |
2013 Q1 | 857.36 Thousand AUD | 0.0% |
2013 Q2 | -301.54 Thousand AUD | -135.17% |
2013 Q4 | -301.54 Thousand AUD | 0.0% |
2012 Q2 | 857.36 Thousand AUD | 843.2% |
2012 FY | - AUD | 811.84% |
2012 Q3 | 857.36 Thousand AUD | 0.0% |
2012 Q1 | -115.36 Thousand AUD | 0.0% |
2012 Q4 | 857.36 Thousand AUD | 0.0% |
2011 Q1 | 217.63 Thousand AUD | 0.0% |
2011 Q2 | -115.36 Thousand AUD | -153.01% |
2011 FY | - AUD | -166.66% |
2011 Q3 | -115.36 Thousand AUD | 0.0% |
2011 Q4 | -115.36 Thousand AUD | 0.0% |
2010 Q4 | 217.63 Thousand AUD | 0.0% |
2010 Q2 | 217.63 Thousand AUD | -44.59% |
2010 Q3 | 217.63 Thousand AUD | 0.0% |
2010 FY | - AUD | -41.65% |
2010 Q1 | 392.77 Thousand AUD | 0.0% |
2009 Q4 | 392.77 Thousand AUD | 0.0% |
2009 Q2 | 392.77 Thousand AUD | 296.37% |
2009 Q1 | -200.01 Thousand AUD | 0.0% |
2009 Q3 | 392.77 Thousand AUD | 0.0% |
2009 FY | - AUD | 253.21% |
2008 Q2 | -200.01 Thousand AUD | 53.26% |
2008 FY | - AUD | 42.96% |
2008 Q4 | -200.01 Thousand AUD | 0.0% |
2008 Q3 | -200.01 Thousand AUD | 0.0% |
2008 Q1 | -427.96 Thousand AUD | 0.0% |
2007 FY | - AUD | -8.5% |
2007 Q2 | -427.96 Thousand AUD | 5.1% |
2007 Q4 | -427.96 Thousand AUD | 0.0% |
2007 Q3 | -427.96 Thousand AUD | 0.0% |
2007 Q1 | -450.94 Thousand AUD | 0.0% |
2006 Q2 | -450.94 Thousand AUD | 61.88% |
2006 FY | - AUD | 41.69% |
2006 Q4 | -450.94 Thousand AUD | 0.0% |
2006 Q3 | -450.94 Thousand AUD | 0.0% |
2006 Q1 | -1.18 Million AUD | 0.0% |
2005 Q4 | -1.18 Million AUD | 0.0% |
2005 Q2 | -1.18 Million AUD | -24.87% |
2005 FY | - AUD | -67.74% |
2005 Q1 | -947.34 Thousand AUD | 0.0% |
2005 Q3 | -1.18 Million AUD | 0.0% |
2004 Q2 | -947.34 Thousand AUD | -50.2% |
2004 Q1 | -630.72 Thousand AUD | 0.0% |
2004 Q3 | -947.34 Thousand AUD | 0.0% |
2004 Q4 | -947.34 Thousand AUD | 0.0% |
2004 FY | - AUD | -67.54% |
2003 Q4 | -630.72 Thousand AUD | 0.0% |
2003 Q3 | -630.72 Thousand AUD | 0.0% |
2003 Q2 | -630.72 Thousand AUD | 0.0% |
2003 FY | - AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Alcidion Group Limited | -4.49 Million AUD | 320.002% |
Artrya Limited | -13.95 Million AUD | 170.88% |
Beamtree Holdings Limited | -331 Thousand AUD | 3088.302% |
Careteq Limited | -826.61 Thousand AUD | 1296.599% |
Doctor Care Anywhere Group PLC | -8.35 Million AUD | 218.402% |
Emyria Limited | -13.03 Million AUD | 175.883% |
Global Health Limited | -1.76 Million AUD | 660.167% |
HITIQ Limited | -2.54 Million AUD | 489.019% |
Intelicare Holdings Limited | -3.02 Million AUD | 427.469% |
ImExHS Limited | -1.25 Million AUD | 886.445% |
Mach7 Technologies Limited | -2.44 Million AUD | 505.042% |
MedAdvisor Limited | 7.04 Million AUD | -40.336% |
Oakridge International Limited | -630.05 Thousand AUD | 1669.913% |
Opyl Limited | -3.2 Million AUD | 408.212% |
PainChek Limited | -9.48 Million AUD | 204.245% |
Pro Medicus Limited | 120.76 Million AUD | 91.809% |
Resonance Health Limited | -457 Thousand AUD | 2264.356% |
Singular Health Group Ltd | -2.88 Million AUD | 442.836% |
Total Brain Limited | -5.49 Million AUD | 280.132% |